
Spruce Biosciences, Inc.
SPRBHealthcare|Biotechnology|US
$46.55
+3.84 (+8.99%)
DCF Value
$61.82
Tangible Book / Share
$34.44
Cash / Share
$39.61
Ownership Breakdown
70.2%
Float
2.9M
Shares Outstanding
2.0M
Float Shares
Major Holders (40)
Combined: 199.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Bradley L. Radoff | Individual | 9.60% | 3,975,000 | Nov 12, 2024 | 13D/G |
| AIGH Capital Management LLC | IA, OO | 9.10% | 250,000 | Jul 27, 2026 | 13D/G |
| Orin Hirschman | HC, IN | 9.10% | 250,000 | Jul 27, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 6.80% | 187,836 | Jul 30, 2026 | 13D/G |
| Boone Peter David Mr | Individual | 6.40% | 68,184 | Nov 24, 2025 | 13D/G |
| Israel A. Englander | Individual | 5.80% | 160,981 | Aug 4, 2026 | 13D/G |
| Millennium Group Management LLC | Other | 5.80% | 160,981 | Aug 4, 2026 | 13D/G |
| Millennium Management LLC | Other | 5.80% | 160,981 | Aug 4, 2026 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 5.80% | 160,981 | Aug 4, 2026 | 13D/G |
| AWM Investment Company, Inc. | Investment adviser | 5.10% | 146,988 | Aug 14, 2026 | 13D/G |
| Armistice Capital, LLC | IA, OO | 4.99% | 2,169,245 | Nov 14, 2024 | 13D/G |
| Steven Boyd | HC, IN | 4.99% | 2,169,245 | Nov 14, 2024 | 13D/G |
| OrbiMed Advisors LLC | Investment adviser | 4.80% | 132,200 | Aug 14, 2026 | 13D/G |
| Ikarian Capital, LLC | Investment adviser | 4.80% | 121,356 | May 7, 2026 | 13D/G |
| Neil Shahrestani | HC, IN | 4.80% | 121,356 | May 7, 2026 | 13D/G |
| Carlyle Holdings I L.P. | Partnership | 4.70% | 50,893 | Feb 18, 2026 | 13D/G |
| CG Subsidiary Holdings L.L.C. | Other | 4.70% | 50,893 | Feb 18, 2026 | 13D/G |
| TC Group, L.L.C. | Other | 4.70% | 50,893 | Feb 18, 2026 | 13D/G |
| Carlyle Investment Management L.L.C. | Other | 4.70% | 50,893 | Feb 18, 2026 | 13D/G |
| Carlyle Genesis UK LLC | Other | 4.70% | 50,893 | Feb 18, 2026 | 13D/G |
| Abingworth LLP | Partnership | 4.70% | 50,893 | Feb 18, 2026 | 13D/G |
| Abingworth Bioventures VII LP | Partnership | 4.70% | 50,893 | Feb 18, 2026 | 13D/G |
| The Carlyle Group Inc. | Corporation | 4.70% | 50,893 | Feb 18, 2026 | 13D/G |
| Carlyle Holdings I GP Inc. | Corporation | 4.70% | 50,893 | Feb 18, 2026 | 13D/G |
| Carlyle Holdings I GP Sub L.L.C. | Other | 4.70% | 50,893 | Feb 18, 2026 | 13D/G |
| Anand Parekh | Individual | 4.49% | 61,670 | May 15, 2026 | 13D/G |
| Alyeska Fund GP, LLC | Other | 4.49% | 61,670 | May 15, 2026 | 13D/G |
| Alyeska Investment Group, L.P. | Investment adviser | 4.49% | 61,670 | May 15, 2026 | 13D/G |
| John P. McKearn, Ph.D. | Individual | 4.20% | 1,759,521 | Jan 10, 2025 | 13D/G |
| Jay Schmelter | Individual | 4.20% | 1,759,521 | Jan 10, 2025 | 13D/G |
| 5AM Opportunities II (GP), LLC | Other | 4.10% | 1,773,000 | Nov 14, 2024 | 13D/G |
| Andrew J. Schwab | Individual | 4.10% | 1,773,000 | Nov 14, 2024 | 13D/G |
| 5AM Opportunities II, L.P. | Partnership | 4.10% | 1,773,000 | Nov 14, 2024 | 13D/G |
| Dr. Kush Parmar | Individual | 4.10% | 1,773,000 | Nov 14, 2024 | 13D/G |
| Wellington Investment Advisors Holdings LLP | Holding company | 3.60% | 48,796 | May 15, 2026 | 13D/G |
| Wellington Group Holdings LLP | Holding company | 3.60% | 48,796 | May 15, 2026 | 13D/G |
| Wellington Management Group LLP | Holding company | 3.60% | 48,796 | May 15, 2026 | 13D/G |
| HealthCap VIII, L.P. | Partnership | 3.40% | 36,640 | Oct 9, 2025 | 13D/G |
| HealthCap VIII GP LLC | Partnership | 3.40% | 36,640 | Oct 9, 2025 | 13D/G |
| OrbiMed Capital LLC | Investment adviser | 2.50% | 67,800 | Aug 14, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 126,607 acquired · 52,257 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Quartel Adrian W | Chief Medical Officer | Jul 27, 2026 | AWARD | 13,000 | — | — | Form 4 |
| Quartel Adrian W | Jul 27, 2026 | OTHER | 0 | — | — | Form 4 | |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Jun 30, 2026 | AWARD | 266 | $4.53 | $1.2K | Form 4 |
| SPIEGELMAN DANIEL K | director | May 21, 2026 | AWARD | 1,700 | $52.70 | $89.6K | Form 4 |
| SIMPSON CAMILLA V | director | May 21, 2026 | AWARD | 1,700 | $52.70 | $89.6K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | May 21, 2026 | AWARD | 1,700 | $52.70 | $89.6K | Form 4 |
| Barretto-Ko Percival | director | May 21, 2026 | AWARD | 1,700 | $52.70 | $89.6K | Form 4 |
| Walbert Keli | director | May 21, 2026 | AWARD | 1,700 | $52.70 | $89.6K | Form 4 |
| Hooks Corwin Dale | Chief Commercial Officer | Mar 9, 2026 | AWARD | 11,000 | — | — | Form 4 |
| Hooks Corwin Dale | Mar 9, 2026 | OTHER | 0 | — | — | Form 4 | |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | Dec 11, 2025 | AWARD | 5,000 | — | — | Form 4 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | Dec 11, 2025 | OPTION EX. | 1,250 | — | — | Form 4 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | Dec 11, 2025 | OPTION EX. | 1,250 | — | — | Form 4 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | Dec 11, 2025 | AWARD | 400 | $104.13 | $41.7K | Form 4 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | Dec 11, 2025 | AWARD | 266 | $104.13 | $27.7K | Form 4 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | Dec 11, 2025 | DISPOSED | 266 | $791.25 | $210.5K | Form 4 |
| Ways Douglas Kirk | director, officer: Interim Chief Medical Officer | Dec 11, 2025 | DISPOSED | 400 | $169.50 | $67.8K | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 31, 2025 | AWARD | 4,690 | $4.53 | $21.2K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 15, 2025 | OPTION EX. | 513 | — | — | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 15, 2025 | TAX W/H | 184 | $80.67 | $14.8K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 15, 2025 | OPTION EX. | 496 | — | — | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 15, 2025 | TAX W/H | 178 | $80.67 | $14.4K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 15, 2025 | OPTION EX. | 513 | — | — | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 15, 2025 | OPTION EX. | 496 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 15, 2025 | OPTION EX. | 1,196 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 15, 2025 | OPTION EX. | 1,480 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 15, 2025 | TAX W/H | 608 | $80.67 | $49.0K | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 15, 2025 | TAX W/H | 752 | $80.67 | $60.7K | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 15, 2025 | OPTION EX. | 1,196 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 11, 2025 | AWARD | 1,666 | $104.13 | $173.5K | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 15, 2025 | OPTION EX. | 1,480 | — | — | Form 4 |
| SPIEGELMAN DANIEL K | director | Dec 11, 2025 | AWARD | 458 | $104.13 | $47.7K | Form 4 |
| SPIEGELMAN DANIEL K | director | Dec 11, 2025 | AWARD | 400 | $104.13 | $41.7K | Form 4 |
| SPIEGELMAN DANIEL K | director | Dec 11, 2025 | AWARD | 88 | $104.13 | $9.2K | Form 4 |
| SPIEGELMAN DANIEL K | director | Dec 11, 2025 | DISPOSED | 88 | $1143.00 | $100.6K | Form 4 |
| SPIEGELMAN DANIEL K | director | Dec 11, 2025 | DISPOSED | 400 | $169.50 | $67.8K | Form 4 |
| SPIEGELMAN DANIEL K | director | Dec 11, 2025 | DISPOSED | 458 | $564.00 | $258.3K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | AWARD | 1,499 | $104.13 | $156.1K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | AWARD | 1,255 | $104.13 | $130.7K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | AWARD | 666 | $104.13 | $69.4K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | AWARD | 400 | $104.13 | $41.7K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | AWARD | 387 | $104.13 | $40.3K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | AWARD | 133 | $104.13 | $13.8K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | DISPOSED | 387 | $108.00 | $41.8K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | DISPOSED | 1,255 | $123.00 | $154.4K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | DISPOSED | 1,499 | $230.25 | $345.1K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | DISPOSED | 133 | $1143.00 | $152.0K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | DISPOSED | 666 | $186.00 | $123.9K | Form 4 |
| GREY MICHAEL G | director, officer: Executive Chairman | Dec 11, 2025 | DISPOSED | 400 | $169.50 | $67.8K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | AWARD | 1,933 | $104.13 | $201.3K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | AWARD | 1,579 | $104.13 | $164.4K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | AWARD | 953 | $104.13 | $99.2K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | AWARD | 933 | $104.13 | $97.2K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | AWARD | 733 | $104.13 | $76.3K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | DISPOSED | 733 | $1506.00 | $1.1M | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | DISPOSED | 1,579 | $123.00 | $194.2K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | DISPOSED | 933 | $344.25 | $321.2K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | DISPOSED | 1,933 | $186.00 | $359.5K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | DISPOSED | 953 | $230.25 | $219.4K | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 11, 2025 | AWARD | 10,000 | $104.13 | $1.0M | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 11, 2025 | DISPOSED | 10,000 | $344.25 | $3.4M | Form 4 |
| SIMPSON CAMILLA V | director | Dec 11, 2025 | AWARD | 400 | $104.13 | $41.7K | Form 4 |
| SIMPSON CAMILLA V | director | Dec 11, 2025 | AWARD | 362 | $104.13 | $37.7K | Form 4 |
| SIMPSON CAMILLA V | director | Dec 11, 2025 | AWARD | 309 | $104.13 | $32.2K | Form 4 |
| SIMPSON CAMILLA V | director | Dec 11, 2025 | AWARD | 173 | $104.13 | $18.0K | Form 4 |
| SIMPSON CAMILLA V | director | Dec 11, 2025 | AWARD | 133 | $104.13 | $13.8K | Form 4 |
| SIMPSON CAMILLA V | director | Dec 11, 2025 | DISPOSED | 362 | $230.25 | $83.4K | Form 4 |
| SIMPSON CAMILLA V | director | Dec 11, 2025 | DISPOSED | 400 | $169.50 | $67.8K | Form 4 |
| SIMPSON CAMILLA V | director | Dec 11, 2025 | DISPOSED | 133 | $1143.00 | $152.0K | Form 4 |
| SIMPSON CAMILLA V | director | Dec 11, 2025 | DISPOSED | 309 | $123.00 | $38.0K | Form 4 |
| SIMPSON CAMILLA V | director | Dec 11, 2025 | DISPOSED | 173 | $108.00 | $18.7K | Form 4 |
| Barretto-Ko Percival | director | Dec 11, 2025 | AWARD | 800 | $104.13 | $83.3K | Form 4 |
| Barretto-Ko Percival | director | Dec 11, 2025 | DISPOSED | 800 | $169.50 | $135.6K | Form 4 |
| Walbert Keli | director | Dec 11, 2025 | AWARD | 3,400 | $88.41 | $300.6K | Form 4 |
| Walbert Keli | Dec 11, 2025 | OTHER | 0 | — | — | Form 4 | |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | OPTION EX. | 1,900 | — | — | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | TAX W/H | 680 | $88.41 | $60.1K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | AWARD | 7,600 | — | — | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 10, 2025 | OPTION EX. | 514 | — | — | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 10, 2025 | TAX W/H | 184 | $85.67 | $15.8K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11, 2025 | OPTION EX. | 1,900 | — | — | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 10, 2025 | OPTION EX. | 514 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 11, 2025 | AWARD | 19,800 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 11, 2025 | OPTION EX. | 4,950 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 11, 2025 | OPTION EX. | 4,950 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 11, 2025 | TAX W/H | 2,194 | $88.41 | $194.0K | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 10, 2025 | OPTION EX. | 1,196 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 10, 2025 | TAX W/H | 428 | $85.67 | $36.7K | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Dec 10, 2025 | OPTION EX. | 1,196 | — | — | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Oct 20, 2025 | OPTION EX. | 2,053 | — | — | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Oct 20, 2025 | TAX W/H | 661 | $148.16 | $97.9K | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Oct 20, 2025 | AWARD | 2,053 | — | — | Form 4 |
| Gharib Samir M. | PRESIDENT AND CFO | Oct 20, 2025 | OPTION EX. | 2,053 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Oct 20, 2025 | OPTION EX. | 4,784 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Oct 20, 2025 | TAX W/H | 1,539 | $148.16 | $228.0K | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Oct 20, 2025 | AWARD | 4,784 | — | — | Form 4 |
| Szwarcberg Javier B. | director, officer: CHIEF EXECUTIVE OFFICER | Oct 20, 2025 | OPTION EX. | 4,784 | — | — | Form 4 |
| Parkman Healthcare Partners LLC | 10 percent owner | Oct 6, 2025 | BUY | 256 | $17.91 | $4.6K | Form 4 |
| Parkman Healthcare Partners LLC | 10 percent owner | Oct 6, 2025 | SELL | 232 | $19.33 | $4.5K | Form 4 |
| Parkman Healthcare Partners LLC | 10 percent owner | Oct 6, 2025 | SELL | 25 | $17.46 | $436.39 | Form 4 |